Zydus and Synthon to Commercialise Novel 505(B)(2) Oncology Product in US
Under the terms of this agreement, Synthon will be responsible for the development, manufacturing and supply of the finished product.
Synthon | 13/02/2025 | By Aishwarya | 116
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy